ADC Stability & Comparability Studies

Antibody-drug conjugates (ADCs) are complex biotherapeutics whose quality can change during storage, transportation, formulation development, manufacturing changes, and process scale-up. Stability and comparability studies are therefore important for understanding product degradation, monitoring critical quality attributes, and evaluating whether changes introduced during development or manufacturing affect product quality.

Protheragen provides ADC stability and comparability studies using fit-for-purpose analytical strategies to monitor changes in molecular integrity, purity, aggregation, charge heterogeneity, DAR, free payload, biological activity, and other relevant quality attributes. Studies can be designed to support formulation development, process optimization, manufacturing changes, scale-up, technology transfer, and CMC development.

Overview of ADC Stability & Comparability Studies

ADC stability studies evaluate how product quality changes under defined storage and stress conditions, while comparability studies assess whether ADC materials produced under different conditions remain sufficiently similar in their relevant quality attributes.

Because ADCs contain an antibody, linker, and potent payload, degradation may occur through multiple pathways, including aggregation, fragmentation, deconjugation, payload-related degradation, oxidation, deamidation, and other molecular changes. A combination of orthogonal analytical methods is therefore used to monitor relevant quality attributes and identify meaningful changes over time.

Comparability assessments apply a similar analytical framework to compare materials generated before and after process changes, scale-up, manufacturing site transfer, formulation changes, or other development activities. The scope of testing can be tailored according to the nature of the change, development stage, and intended use of the study.

Fig.1 ADC instability pathways, intervention points, and mitigation strategies. (Torres-Dias, L., et al., 2026)

Our Services

Key Quality Attributes for Comparability Assessment

The analytical scope of a comparability study is determined by the nature of the change and its potential impact on product quality.

Not every study requires all attributes. The analytical panel is selected according to the type of change, development stage, risk assessment, and intended use of the comparison.

Stability & Comparability Study Workflow

Stability and comparability studies are designed according to the ADC molecule, development stage, study objectives, and potential impact of the conditions or changes being evaluated. A structured workflow integrates risk-based study design with orthogonal analytical testing to monitor relevant quality attributes, investigate observed changes, and support an overall assessment of product quality and consistency.

Supporting Analytical Technologies

Depending on study objectives, stability and comparability programs may incorporate:

Analytical methods can be selected from established development programs or further optimized and qualified or validated where required for the intended application.

Why Choose Protheragen

• Integrated Stability & Comparability Strategy

Stability and comparability studies can be coordinated with ADC analytical development and structural characterization to maintain analytical continuity throughout the program.

• ADC-Specific Quality Assessment

Study designs can focus on ADC-specific attributes such as DAR, drug distribution, conjugation-related changes, free payload, aggregation, charge heterogeneity, and biological activity.

• Fit-for-Purpose Study Design

Storage conditions, time points, analytical panels, and comparability scope can be adapted according to development stage, study objectives, and the nature of the process or formulation change.

• Orthogonal Analytical Characterization

Multiple analytical approaches can be combined to investigate observed changes and distinguish molecular degradation from analytical variability.

• Support Across Development Stages

Stability and comparability activities can support early formulation development, clinical development, process optimization, scale-up, technology transfer, manufacturing changes, and later-stage CMC activities.

Stability and comparability studies provide important evidence for understanding how ADC quality changes during storage and how manufacturing, formulation, scale-up, or site changes may affect product characteristics. By combining fit-for-purpose stability designs with orthogonal analytical characterization, Protheragen supports the evaluation of molecular integrity, purity, aggregation, charge heterogeneity, DAR, drug distribution, free payload, structural attributes, and biological activity. Contact us to discuss your ADC stability or comparability study requirements and develop a fit-for-purpose analytical strategy for your development program.